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Background: Primary hyperparathyroidism (PHPT) is often found on routine blood tests, at a relatively asymptomatic
stage. However many studies suggest different systemic effects related to PHPT, which could be enhanced by an
abnormal cortisol release due to chronic stress of hyperparathyroidism. Being PHPT frequently found in the 6th to 7th
decade of life, a careful and multifaceted approach should be taken.
Case presentation: We report the case of an elderly patient with symptomatic PHPT and incidental pulmonary
embolism. He was treated with hydration, zoledronic acid, cinacalcet and high-dose unfractionated heparin. Parathyroid
surgery was successfully performed, but patient’s conditions suddenly worsened because of a transient thyrotoxicosis,
probably induced by a previous exposure to iodine load and/or thyroid surgical manipulation. A short-term treatment
with beta-blockers was introduced for symptomatic relief. The patient also presented a transient hypercortisolism with
elevated ACTH, likely due to stress related not only to aging and hospitalization but also to PHPT, resolved only four
months after parathyroid surgery.
Conclusion: Chronic hyperparathyroidism has been linked with increased all-cause mortality. A functional chronic
hypercortisolism could be established, enhancing PHPT related disorders. Only parathyroid surgery has been
demonstrated to cure PHPT and complications related, showing similar outcome between older and younger
patients. However, the management of post-operative period should be more careful in fragile patients. In particular,
the early diagnosis and treatment of a transient post-operative thyrotoxicosis could improve recovery. Due to the
increase in prevalence and the evidence of many related complications even in asymptomatic PHPT, expert
opinion-based guidelines for surgical treatment of PHPT should be developed especially for elderly patients.
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Functional hypercortisolismBackground
Primary hyperparathyroidism (PHPT) is the third most
common endocrinopathy seen today, frequently found in
the 6th to 7th decade of life. PHPT mainly is a sporadic
disorder, caused in 85% of the cases by a single adenoma,
in 15% by multi-gland disease and rarely by parathyroid* Correspondence: chiara.sabbadin.1@studenti.unipd.it
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unless otherwise stated.carcinoma. Less than 10% of cases are inheritable, often
associated with multi-gland hyperplasia. The most
common presentation of PHPT is an asymptomatic hy-
percalcemia, incidentally found on routine blood tests.
However, many patients may suffer from minimal
symptoms such as asthenia, constipation, polyuria,
hypertension and neuro-psychiatric complications [1].
In some cases a renal colic is the first presentation of
the disease. In older patients, concomitant morbidity andal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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plications, and impact the management of PHPT [2].
In this paper we report a complex case of an elderly
patient with symptomatic PHPT associated with a
functional transient hypercortisolism, resolved only
after parathyroid surgery. The post-operative period
was also characterized by a symptomatic transient
thyrotoxicosis, probably induced by previous exposure
to iodine load and/or thyroid surgical manipulation.
The early diagnosis and treatment of this condition im-
proved final outcome.
Case presentation
An 80-year old man was admitted to a general hospital
for polyuria, vomiting, weight loss, worsening asthenia,
myalgia and progressive cognitive impairment. He had a
personal history of hypertension and type 2 diabetes,
treated with losartan and metformin respectively. On
physical examination he was sleepy, apyretic, hyperten-
sive (upright blood pressure 150/100 mmHg) and
tachycardic (100 beats for minute). He did complain of
dyspnea, dry skin and mucosa and muscle weakness,
without bone pain and neurological alterations. Bio-
chemical assays revealed hypernatremia (149 mmol/L),
severe hypercalcemia (4.08 mmol/L), hypophosfatemia
(0.62 mmol/L), elevated levels of PTH (252 ng/L),
reduced vitamin D (32 nmol/L) and slight renal failure
(urea 8.7 mmol/L, creatinine 112 μmol/L). Blood count,
liver and thyroid function were normal (Table 1). The
electrocardiogram did not show remarkable signs of hy-
percalcemia. A cranial computed tomography (CT) scan
excluded acute cerebrovascular events. A CT pulmonary
angiography detected partial thrombosis in three segmen-
tal branches of the right upper lobe pulmonary artery.
Doppler ultrasound (US) revealed a deep vein thrombosis
of the left posterior tibial vein. The patient was treated with
isotonic saline hydration, furosemide, supplementation ofTable 1 Principal biochemical parameters of the patient befo
Parameter Normal range 1 month b
Ca (mmol/L) 2,1-2,5
P (mmol/L) 0,8-1,4
PTH (ng/L) 5-27
ACTH (ng/L) 10-50
Morning salivary cortisol (ng/mL) 2,6-15,3
Late-night salivary cortisol (ng/mL) 0,1-5,2
Daily urinary cortisol (nmol/24 h) 30-193
Serum cortisol after 1 mg DST (nmol/L) <50
TSH (mIU/L) 0,2-4
FT4 (pmol/L) 9-22
FT3 (pmol/L) 3,9-6,8
DST: dexamethasone soppression test.vitamin D and an injection of zoledronate 4 mg, with a
mild improvement of hypercalcemia and related symp-
toms. Daily high-dose unfractionated heparin was also
administered. The patient was then transferred to our
Endocrine Unit and treated with cinacalcet, with decrease
of PTH, calcemia and calciuria values. Amlodipine and in-
sulin were also added for worsening hypertension and dia-
betes. Neck US revealed an enlarged thyroid with normal
vascular pattern and at the lower pole of the left thyroid
lobe a hypoechoic vascular nodule (14.7×10.5×9 mm),
consistent with enlarged parathyroid. A sesta-MIBI scin-
tigraphy showed a homogeneous tracer uptake over the
thyroid in the early images and a remaining modest up-
take in the lower left thyroid lobe in the later images; no
other abnormal or ectopic uptake was found. Dual-energy
x-ray absorptiometry revealed an osteopenia; all the
radiological exams did not find brown tumors. Because
of multiple co-morbidities, further investigations were
performed to exclude other endocrine disorders: urinary
metanephrine and normetanephrine values were normal,
while plasma morning ACTH and daily urinary free
cortisol were increased with impaired circadian corti-
sol rhythm, evaluated in two different measurements;
serum cortisol after 1 mg overnight dexamethasone
administration was not suppressed (Table 1). Direct ab-
domen CT was negative for adrenal diseases. Pituitary
magnetic resonance imaging (MRI) evidenced a round
mass, about 4 mm, without enhancement after gadolinium
injection, in the left lateral portion of adenohypophysis,
consistent with microadenoma. Screening for mutations
of MEN genes was negative. The other pituitary hormones
were normal. Because of the patient’s general conditions
and a probably stress-induced hypercortisolism, no other
investigations were performed, giving priority to the surgi-
cal resolution of PHPT. Bilateral neck exploration was
performed with removal of the upper right parathyroid
and both the lower and the upper left parathyroid gland,re and after surgery for primary hyperparathyroidism
efore surgery 4 days after surgery 4 months after surgery
4,2 2,5 2,2
0,6 0,7 1,1
252 <4 12
128 126 38
13,1 - 12,2
15,8 - 3,4
557 281 80
223 - 30
1,04 0,03 1,17
19,9 26,9 18,7
3,9 10,4 4,1
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39 ng/L). The histological diagnosis was consistent with
multi-glandular hyperplasia. Laboratory tests showed a de-
crease of calcium and PTH levels, treated with oral cal-
cium and calcitriol. However, four days after surgery the
patient developed a sinusal tachycardia, mild heart failure
and agitation alternating with stupor, without evidence of
infection nor of volemic imbalance. Further investigation
revealed suppressed TSH, elevated free T4 and T3 values
(Table 1), with undetectable anti-thyroid and TSH recep-
tor antibodies. Thyroid palpation was not painful. The
post-operatory 99mTcO4 scintigraphy showed a reduced
tracer uptake over the thyroid, especially in the lower
left thyroid lobe, consistent with an inflammatory area
(Figure 1). Suspecting interference by the iodinated
contrast used for pulmonary angio-CT about a month
before, urinary iodine excretion was measured, resulting
elevated (935 μg/L, normal range 100–200). Considering a
possible dual pathogenesis of thyrotoxicosis, both de-
structive and iodine-induced, the patient was treated
with atenolol for symptomatic relief. Two months after
surgery, thyroid function and ioduria were normal and
beta-blocker was progressively stopped; 1 mg overnight
dexamethasone test (DST) was still pathological. After
other two months, calcium-phosphate balance was nor-
mal and serum PTH was near the lower limit of normal,
therefore calcium and calcitriol supplementation were
continued. Adrenal function was finally normalized with
adequate cortisol suppression after 1 mg overnight DST
(Table 1). Pituitary MRI confirmed the presence of aFigure 1 99mTcO4 scintigraphy, performed 4 days after
parathyroid surgery, evidences a reduced uptake in total
thyroid tissue, especially in the lower left lobe.microadenoma, compatible with a non-secretory inciden-
taloma, in careful biochemical and radiological follow-up.
Discussion
We report an elderly patient presenting symptomatic
hypercalcemia with moderate hemodynamic and neuro-
psychiatric failure. The detection of hypercalcemia and
elevated PTH levels was diagnostic of PHPT. The bio-
chemical/clinical presentation could also raise the suspi-
cion of parathyroid carcinoma, which was excluded by
the histological examinations. Rehydration was the first
measure to take in this patient, not only to correct de-
hydration and improve renal failure, but also to dilute
calcium excretion. Bisphosphonate administration was
effective in reducing calcium levels and bone resorption,
in particular recent controlled trials demonstrated the
superiority of zoledronate compared with previous treat-
ments [3]. The addition of cinacalcet may be useful in the
elderly or in not-surgical candidates, being well tolerated
[4]. Parathyroid surgery is the only definite cure for PHPT,
but the risks and benefits of surgery should be extensively
considered in the elderly, given their more fragile state
and co-morbidities [5]. Preoperative imaging with ultra-
sonography and scintigraphy may be helpful before
elective surgery and in suspected parathyroid carcin-
oma, even if their sensitivity drops in detecting multi-
glandular disease, as happened in our case report.
Our finding of a transient thyrotoxicosis after para-
thyroid surgery could be due to a dual pathogenesis: a
destructive thyroiditis and/or an iodine-induced hyper-
thyroidism. The first condition is fairly unknown and
underestimated since the symptoms could be masked
by other postoperative events [6]. Thyrotoxicosis seems to
be related to an increased release of thyroid hormones
and/or autoantigen during surgical manipulation, which
could reactivate underlying autoimmune thyroiditis [7]. It
could be influenced by other mechanisms, like preopera-
tive hypercalcemic setting, pre-existing goiter and difficult
parathyroid glands identification during surgical explor-
ation [8]. Our patient had an euthyroid goiter, without
abnormal MIBI-uptake in preoperative investigations nor
previous or underlying autoimmune thyroiditis. Retro-
spectively, the only apparent risk factors were the goiter,
the previous pronounced hypercalcemic condition and the
occasional finding of a multi-gland disease.
The second possible cause of transient thyrotoxicosis
could be related to the previous iodinated contrast media
exposure, leading to hypersecretion of thyroid hormones.
This phenomenon, known as the Jod-Basedow effect, usu-
ally develops over 2 to 12 weeks, typically in old patients
with underlying thyroid disease or living in areas of iod-
ine deficiency. Exposure to a large iodine load can also
cause acute destructive thyroiditis in people without
pre-existing thyroid disorders [9]. TcO4-scintigraphy
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since pertechnetate is trapped by thyroid, but not orga-
nified and the resulting tracer uptake may be reduced.
As happened in our case, the assessment of urinary iod-
ine concentration may be helpful [10]. Some researchers
have investigated the incidence and the role of prophy-
lactic measures to reduce the risk of iodine-induced
thyrotoxicosis, without conclusive findings [11]. In our
case the concomitant neck surgery could have been a
precipitating factor in the pathogenesis of hyperthyroidism.
Both these conditions are usually self-limited and anti-
thyroid drugs are not indicated. However, a short-term
treatment with beta-blockers could be required for symp-
tomatic relief, especially in fragile patients.
Since chronic hyperparathyroidism has been linked
with increased all-cause mortality, in asymptomatic and
elderly patients the optimal timing for parathyroidectomy
is controversial [12]. Cardiovascular complications are the
leading cause of this increased mortality [13], linked not
only to mineral homeostasis disruption but also to a direct
effect of PTH on cardiovascular structures [14]. The
complexity of PTH functions is further highlighted by
data suggesting a bidirectional link between PTH and the
renin-angiotensin-aldosterone-system, playing a synergic
role in enhancing metabolic and cardiovascular complica-
tions [15]. Several studies have also evidenced an altered
hypotalamic-pituitary-adrenal (HPA) axis in PHPT, poten-
tially contributing to cortical bone damage [16]. In vitro
evidence supports a stimulatory effect of PTH on cortisol
secretion [17] and of calcemia on ACTH release [18]. In
vivo data show a hypercortisolism, loss of circadian
rhythm and lack of cortisol suppression after low-dose
DST in PHPT [19], which are not always recovered after
surgical cure, as happened in our case.
Alteration of cortisol expression and its circadian vari-
ability are also typical of aging, hospitalization, psychiatric
and stress conditions [20]. False-positive results of the
1 mg DSTcould be influenced by absorption, liver or renal
alterations and the use of alcohol or drugs inducing
CYP3A4. Being PHPT a long-standing disease frequently
affecting old patients, the activation of adrenal function
seems to recall a functional hypercortisolism due to chronic
stress, which could be preserved by aging and other co-
morbidities, enhancing the damaging effects of prolonged
exposure to stress hormones [21].
In our case, HPA axis was evaluated because of mul-
tiple co-morbidities of the patient. The data suggestive
of Cushing’s syndrome were the incidental pulmonary
thrombo-embolism, the uncontrolled hypertension and
diabetes and the evidence of a pituitary microadenoma;
however, the absence of typical stigmata and the presence
of many confounding factors made the diagnosis uncer-
tain. After discharge, further investigations excluded a
Cushing’s syndrome, but the slow normalization of HPAaxis only after four months seems to be related to the
resolution not only of the acute stressful condition but
also of PHPT.
This complex picture suggests that parathyroid surgery
may improve the prognosis, normalizing also HPA axis,
which could contribute to PHPT related pathologies,
such as bone metabolism, psychiatric, metabolic and car-
diovascular disorders [22].
Conclusions
There is ample evidence that PHPT is associated with
HPA axis alterations, which could be involved in the in-
creased metabolic, cardiovascular and neuropsychiatric
complications. A wide variety of medical therapies are
available; however, only parathyroid surgery has been
demonstrated to cure PHPT and complications related,
showing similar outcome between older and younger pa-
tients. A transient thyrotoxicosis is a fairly underestimated
condition, which could be secondary to previous iodinated
contrast media exposure or to thyroid manipulation dur-
ing parathyroid surgery. The early diagnosis and treatment
of this complication may increase a successful recovery,
especially in fragile patients.
In conclusion, due to the increase in prevalence and
the evidence of many related complications even in
asymptomatic PHPT, expert opinion-based guidelines
for surgical treatment of PHPT should be developed
especially for elderly patients.
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